Parametric Portfolio Associates’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$4.48M Buy
90,414
+23,397
+35% +$1.16M ﹤0.01% 1923
2021
Q4
$3.41M Buy
67,017
+327
+0.5% +$16.7K ﹤0.01% 2113
2021
Q3
$3.72M Buy
66,690
+17,545
+36% +$979K ﹤0.01% 2047
2021
Q2
$2.1M Buy
49,145
+9,347
+23% +$400K ﹤0.01% 2403
2021
Q1
$1.66M Buy
39,798
+2,402
+6% +$100K ﹤0.01% 2895
2020
Q4
$1.74M Buy
37,396
+12,289
+49% +$572K ﹤0.01% 2753
2020
Q3
$1.07M Buy
25,107
+165
+0.7% +$7.01K ﹤0.01% 2890
2020
Q2
$1.2M Sell
24,942
-1,255
-5% -$60.2K ﹤0.01% 2818
2020
Q1
$1.21M Sell
26,197
-5,426
-17% -$250K ﹤0.01% 2694
2019
Q4
$1.9M Sell
31,623
-4,496
-12% -$270K ﹤0.01% 2723
2019
Q3
$2.04M Sell
36,119
-4,975
-12% -$281K ﹤0.01% 2620
2019
Q2
$2.29M Buy
41,094
+7,062
+21% +$393K ﹤0.01% 2580
2019
Q1
$1.72M Buy
34,032
+14,925
+78% +$753K ﹤0.01% 2737
2018
Q4
$770K Buy
19,107
+4,896
+34% +$197K ﹤0.01% 3123
2018
Q3
$985K Buy
14,211
+1,965
+16% +$136K ﹤0.01% 3105
2018
Q2
$927K Sell
12,246
-6,479
-35% -$490K ﹤0.01% 3093
2018
Q1
$987K Sell
18,725
-1,018
-5% -$53.7K ﹤0.01% 3026
2017
Q4
$1.06M Buy
19,743
+3,211
+19% +$172K ﹤0.01% 2994
2017
Q3
$986K Buy
16,532
+9,017
+120% +$538K ﹤0.01% 3051
2017
Q2
$593K Buy
7,515
+3,679
+96% +$290K ﹤0.01% 3262
2017
Q1
$318K Sell
3,836
-12,799
-77% -$1.06M ﹤0.01% 3403
2016
Q4
$1.32M Buy
16,635
+12,592
+311% +$999K ﹤0.01% 2661
2016
Q3
$283K Buy
+4,043
New +$283K ﹤0.01% 3441
2016
Q1
Sell
-2,337
Closed -$207K 4047
2015
Q4
$207K Buy
+2,337
New +$207K ﹤0.01% 3722